Announced first results as standalone firm, Kenveu doesn’t downplay significance of J&J announcing its plan for selling shares from nearly 90% ownership it retained after spinning off Kenvue out in May.
Investors’ view of Kenvue Inc. may have been captured well when the firm announced its quarterly results on 20 July.
Join thousands of industry professionals who rely on HBW Insight for daily insights
Already a subscriber?
Private equity firm CD&R takes control of Opella while Sanofi retains a sizeable stake and nets €10bn.
Wellnex bringing brands such as Pain Away, Wakey Wakey and Nighty Night to UK market shortly after gaining admission to the the AIM market of the London Stock Exchange.
The firms recently announced they will operate as combined company LXE Hearing marketing Eargo’s namesake line and hearX’s Lexie brands. Eargo majority owner Patient Square Capital added $100m to its investment.
Consumer health player Karo is changing hands from EQT to KKR in a deal thought to value the Stockholm-based firm at over €2.5bn.
